2019 ADA Meds Management Update - Diabetes Education Services
Diabetes Boot Camp – Class 5
What the studies say about targets for glycaemic control (including hypoglycaemia)
ADA, EASD consensus report 2019 JDC monthly diabetes newsletter. Issue 134 December, 2019
Faculty of Medicine, The Chinese University of Hong Kong
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis - The Lancet
8. Non-insulin therapies — ITSDIABETES ITS Inpatient Diabetes Training & Support
Glucose-lowering medication in type 2 diabetes: overall approach. - ppt download
JCM | Free Full-Text | Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis - The Lancet Diabetes & Endocrinology
Complexity of type 2 diabetes
Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA
How to Use the American Diabetes Association's Type 2 Diabetes Algorithm Disclosures of Interest
Glucose-lowering medication in type 2 diabetes: overall approach | Download Scientific Diagram
Initiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions | American Board of Family Medicine
Complexity of type 2 diabetes
Glucose-lowering medication in type 2 diabetes: overall approach | Download Scientific Diagram
Molecules | Free Full-Text | Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs
Use of glucose-lowering medications in the management of type 2 diabetes | Download Scientific Diagram
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink
Summary of the overall approach to glucose-lowering medications in type... | Download Scientific Diagram
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes | NEJM
